FibroBiologics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CASCADE FINANCIAL PARTNERS, LLC | 08/04/2026 | 108.83 K | $103.14 K | 562.45% | 2.88% |
| FUND EVALUATION GROUP, LLC | 08/07/2026 | 51.79 K | $49.09 K | 0.00% | 1.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 30.30 K | $28.72 K | 2.33% | 0.80% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 27.77 K | $26.33 K | -58.96% | 0.74% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 24.31 K | $23.04 K | 100.00% | 0.64% |
| BLACKROCK, INC. | 08/07/2026 | 18.24 K | $17.28 K | -26.00% | 0.48% |
| BARCLAYS PLC | 08/14/2026 | 7.24 K | $6.86 K | 100.00% | 0.19% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 6.38 K | $6.05 K | 0.00% | 0.17% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 4.73 K | $4.48 K | 927.83% | 0.13% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 2.40 K | $2.28 K | 1,461.04% | 0.06% |
| ROYAL BANK OF CANADA | 08/14/2026 | 1.52 K | $1.00 K | 100.00% | 0.04% |
| UBS GROUP AG | 08/13/2026 | 1.07 K | $1.02 K | -81.24% | 0.03% |
| ISLAY CAPITAL MANAGEMENT, LLC | 08/13/2026 | 169 | $160 | 0.00% | 0.00% |
| GROVE BANK & TRUST | 07/07/2026 | 100 | $95 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 64 | $61 | -3.03% | 0.00% |
| ALLWORTH FINANCIAL LP | 08/11/2026 | 13 | $13 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| WESTERN WEALTH MANAGEMENT, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
FibroBiologics Inc institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of FibroBiologics Inc. The most heavily invested institutionals were:
Cascade Financial Partners, LLC: 108,828
Fund Evaluation Group, LLC: 51,794
GEODE CAPITAL MANAGEMENT, LLC: 30,299
VANGUARD CAPITAL MANAGEMENT LLC: 27,769
Qube Research & Technologies Ltd: 24,313
BlackRock, Inc.: 18,238
7.55% of FibroBiologics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 2.47 M shares in the last 24 months. This purchase volume represents approximately $988.93 K in transactions.